Revenue ₹1,024 Cr
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Akums Drugs and Pharmaceuticals LimitedAkums Drugs reported a mixed Q1 FY26.
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.